Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study (Q84305962)
Jump to navigation
Jump to search
scientific article published on 01 June 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study |
scientific article published on 01 June 2011 |
Statements
Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study (English)
Naoyuki Kamatani
Shin Fujimori
Toshikazu Hada
Tatsuo Hosoya
Kenjiro Kohri
Toshitaka Nakamura
Takanori Ueda
Tetsuya Yamamoto
Yuji Matsuzawa